About Thomas Cahill
Thomas Cahill is a director at Prime Medicine.
Form D filings name Thomas Cahill as a director at Chroma Medicine.
Thomas Cahill reports to the SEC as a director of 1 public company.
Thomas Cahill first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Cahill in the role, so the role may have started earlier or lasted longer.
PI
Prime Medicine, Inc.
Director
2022 – 2026 · Public company (PRME)
Key Colleagues at Startups
The people Thomas Cahill works with at each company, as listed on that company's latest Form D.
Chroma Medicine, Inc. · Form D/A, Sep 1, 2023
BC
Bihua Chen
Director
GG
George Golumbeski
Director
KB
Kevin Bitterman
Director
BK
Brett Kaplan
Chief Financial Officer
VM
Vic Myer
Executive officer
MK
Michael Kelly
Director
CB
Catherine Stehman-Breen
Executive officer and director
PP
Paola Pozzi
Director
JM
Jeff Marrazzo
Director